Alzheimer Drug Lecanemab Gains Traditional FDA Approval

Emily Harris

View at source ↗Article44 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1001/jama.2023.12548
Published
Jul 19, 2023
Venue
JAMA
DOI
10.1001/jama.2023.12548
PubMed
37466999
Categories
Alzheimer's disease research and treatments
Provenance
openalex

Topics